Boston Scientific Noncontrolling Interests Activity and Other decreased by 66.7% to $3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 130.0%, from -$10.00M to $3.00M. Over 2 years (FY 2023 to FY 2025), Noncontrolling Interests Activity and Other shows an upward trend with a -69.8% CAGR.
pm_noncontrolling_interest_activity_other| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$19.25M | -$19.25M | -$19.25M | -$19.25M | -$250.00K | -$250.00K | -$250.00K | -$250.00K | -$10.00M | $9.00M | -$1.00M | $9.00M | $3.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +98.7% | +0.0% | +0.0% | +0.0% | <-999% | +190.0% | -111.1% | >999% | -66.7% |
| YoY Change | — | — | — | — | +98.7% | +98.7% | +98.7% | +98.7% | <-999% | >999% | -300.0% | >999% | +130.0% |